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Summary 
We compared the conformation of empty and peptide-loaded class I major histocompatihility 
complex  (MHC)  molecules at  the cell  surface.  Molecular  conformations were  analyzed by 
fluorescence resonance energy transfer (FRET) between fluorescent-labeled Fab fragments bound 
to the or2 domain of the MHC  heavy chain and fluorescent-labeled Fab  fragments bound to 
~/2-microglobulin. No FRET was found between Fab fragments bound to empty H-2K b, but 
FRET was detected when empty H-2K b molecules were loaded with peptide. The magnitude 
of FRET depended on the sequence of the peptide used. The results imply that empty H-2K  b 
molecules are in a relatively extended conformation, and that this conformation becomes more 
compact when peptide is bound. These changes, which are reflected in peptide-dependent binding 
of monoclonal antibodies, affect the surfaces  of MHC molecules available for contact with T 
cell receptors and hence may influence T  cell-receptor recognition of MHC  molecules. 
T 
he MHC antigens are polymorphic cell surface glyco- 
proteins with critical roles in the development of im- 
mune responses (1). The class I MHC complex consists of 
a polymorphic heavy chain, which associates with an anti- 
genic peptide and a nonpolymorphic light chain/32-micro- 
globulin  l (/32m) (2-5). This trimolecular complex is required 
for stable cell surface expression of class I MHC molecules. 
Some mutant cell lines, including RMA-S, T2, and EE2H3, 
have been derived that fail to associate  peptides with class 
I MHC molecules (6-11). These cell lines produce class I MHC 
molecules that are either devoid of endogenous antigenic pep- 
tides or may contain low affinity MHC-binding peptides. 
These MHC molecules are largely retained in the endoplasmic 
reticulum, where they are degraded. Functionally, these class 
I molecules are "empty" in that they are unstable at physio- 
logical temperature, and high affinity MHC-binding peptides 
can be loaded into these empty MHC molecules (8,  11). 
The structural bases for the instability of empty MHC mol- 
ecules and their stabilization by exogenous peptides in situ 
have not been characterized.  In contrast, the three-dimensional 
structure of peptide-loaded MHC molecules has been well 
1 Abbreviations used in this paper: 13zm, /32-microglobulin; FRET, flu- 
orescence  resonance  energy  transfer; TxR, Texas red; VSV NP, vesicular 
stomatitis virus nucleoprotein. 
characterized (12-17). Three-dimensional x-ray crystallographic 
solutions of all of the solved structures indicate that the peptide- 
binding groove consists of two sides composed of ot helices 
and a base formed by strands of ~-pleated sheets (12-14). An- 
tigenic peptide fragments bind to the class I peptide-binding 
groove in an extended conformation, and some peptides bulge 
out from the central portion of the peptide-binding groove 
(15,  17,  18). 
An important  question in understanding the molecular 
mechanisms T  cells use to recognize antigenic peptides is 
whether only exposed variable parts of a peptide are recog- 
nized by TCRs or if buried residues of the antigenic peptide 
influence T cell recognition by altering the MHC conforma- 
tion. Previously, we and others (19-23) have shown that sero- 
logical epitopes expressed on MHC molecules loaded with 
specific peptides were peptide dependent. Whereas peptide- 
dependent serological epitopes could be secondary to pep- 
tide side chains interfering with access to certain mAb-binding 
sites  on  MHC  molecules,  substitution  of buried  anchor 
residues also affected the binding of mAbs (19, 20, 23). This 
supports the hypothesis that peptide-dependent serological 
epitopes reflect conformational changes in H-2K b molecules. 
Experiments analyzing the three-dimensional structure of a 
soluble  purified  class  I  molecule  cocrystalized with  two 
different peptides showed that the conformation of the MHC 
molecule around the groove depends on the particular pep- 
tide bound  (15,  24,  25).  Recent work analyzing a larger 
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showed small differences in the MHC conformation (17). In 
these studies, the structure of the bound peptide was thought 
to be the essential determinant of the antigenic identity of 
the MHC-peptide complex. All of these studies indicate that 
peptides influence exposed MHC residues,  thus supporting 
a role for the recognition of "altered" MHC  by TCRs. 
Class I MHC conformation in situ, the structure of empty 
class  I  MHC  molecules,  and the conformation of peptide- 
loaded class I MHC molecules may be probed by use of the 
biophysical technique of fluorescence resonance energy transfer 
(FRET)  (26).  This  technique  detects  proximity  between 
fluorescent  donor  and  acceptor  molecules  in  terms  of 
quenching of donor molecules and enhanced fluorescence of 
acceptor molecules. If r is the distance between donor and 
acceptor, then the magnitude of FRET varies as r -6. For the 
commonly used donor and acceptor pairs of fluorescein and 
rhodamine,  a 25% change in r results in an 85% change in 
FRET. Thus,  small changes in molecular conformation can 
be detected by FRET. This method has been used to analyze 
MHC molecules on intact cells and detects features of class 
I  MHC  structure  (27) and  the proximity of class I  MHC 
molecules  to  one another  (28). 
The availability of cells expressing empty MHC molecules 
allows one to quantitatively load cell surface MHC  mole- 
cules with antigenic peptides. These uniformly loaded MHC 
molecules help amplify signal differences detected by FRET. 
Using this approach, we find that H-2K  b molecules exist in 
a variety of conformational states as evidenced by differences 
in FRET and in the binding of mAbs.  Empty H-2K  b mol- 
ecules have a flexible and extended conformation. This "open" 
intermediate is accessible by peptides. Upon peptide binding, 
H-2K  b  molecules  adopt  a  more  compact  conformation. 
Since the amount of FRET depends on the sequence of the 
bound peptide,  it appears that  this compact MHC confor- 
mation is influenced by the peptide. 
Materials  and  Methods 
Cell Transfections and Culture Conditions.  E-3K  b cells were es- 
tablished as previously described (19) by transfecting a cDNA en- 
coding  H-2K  b (29)  into  EE2H3  cells  via  calcium  phosphate/ 
DNA-mediated transfection. EE2H3 is an embryonic cell line that 
expresses mRNA  for both the class I heavy chain and B2m but 
only expresses low levels of cell surface class I MHC molecules (30). 
These cells have defects in TAP gene expression, which accounts 
for the low level of cell  surface  MHC  molecules.  These MHC 
molecules are empty and, similar to other empty class I MHC mol- 
ecules (11, 31), they are temperature sensitive and can be quanti- 
tatively loaded with MHC-binding peptides.  Previously we char- 
acterized H-2K  b molecules expressed on the transfected E-3K  b cells 
and showed that they are also empty in that they can be quantita- 
tively loaded with specific H-2Kb-binding peptides  but not with 
other irrelevant peptides or peptides that bind to other MHC mol- 
ecules (19). 
E-3K  b cells were maintained by 1:20 passage three times weekly 
in RPMI-1640 supplemented with 2 mM glutamine, nonessential 
amino acids, 50/zg/ml gentamicin, 5  x  10 -5 M 2-ME, and 10% 
FCS (Hyctone Laboratories,  Inc., Logan, UT). 
Peptide Loading of Cells.  E-3K  ~ cells were incubated at 25~ 
overnight in FCS-containing  RPMI-1640 medium with or without 
human 3zm (5  x  10 -7 M) (Sigma Chemical Co., St. Louis, MO) 
in a 5%  CO2 incubator. In the morning,  E-3K  b cells were in- 
cubated with antigenic peptides (100 ~M) in FCS-containing RPMI- 
1640 medium for 1 h at 25~  and then for an additional 2 h at 
37~  An aliquot of the cells, which was not incubated with any 
peptide,  was  maintained at 22~  At the end of the incubation 
period, cells were washed extensively to remove all of the excess 
peptides that did not bind to MHC molecules and prepared for 
flow microfluorometric analysis by staining with various mAb and 
for FRET analysis as described  below. 
PeFtides.  Peptides were made in the Johns Hopkins University 
Biopolymer Laboratory peptide synthesis facility by F-MOC chem- 
ical synthesis  and then purified by preparative HPLC. The two 
H-2Kb-binding peptides  used in these experiments were derived 
from either OVA amino acid residues 257-264 (32, 33) or vesicular 
stomatitis virus nucleoprotein (VSV NP) amino acid residues 52-59 
(34) peptides.  Sequences of the synthetic peptides were confirmed 
by amino acid analysis and peptide sequencing. 
mAbs.  The H-2Kb-reactive mAbs used in these experiments 
have previously been mapped to binding sites on either the cd do- 
main (20.8.4) (35) or the or2 domain (5F1, 28.8.6, and 34.4.20) 
(36, 37) of H-2K  b. Fab fragments of mAb 5F1 and BBM.1 were 
prepared as previously described (38). For the Fab fragments used 
in these experiments, the fluorescein/protein molar (m/m) ratio 
was  1.5 for 5F1, and the Texas red (TxR)/protein ratio was 0.8 
for BBM.1.  In  the reciprocal energy transfer experiments, the 
TxR/protein (m/m) ratio was 1.9 for 5F1 and the fluorescein/pro- 
tein ratio was  2.8 for BBM.L 
Assay ofFab A~nity.  Cells were prepared for binding assay by 
incubation overnight with human 32m (5  x  10-7 M  final con- 
centration). The next morning, cells were pulsed with the OVA 
or VSV peptides as described (100/zM final concentration). At the 
end of the incubation period, cells were harvested and stained with 
various concentrations of fluorescein-labeled  5F1 (F1-5F1) or flu- 
orescein-labeled BBM.1 (F1-BBM.1) Fab fragments. Mean channel 
fluorescence  data were normalized to equivalent  soluble  fluores- 
cein molecules by use of standardized fluorophore-coupled beads 
(Flow Cytometry Standards Corp., Research Triangle Park, NC). 
Nonspecific binding plus autofluorescence for F1-5Fl-labeled cells 
were determined by the addition of a 50-fold molar excess of unla- 
beled mAb, 5F1. Nonspecific binding plus autofluorescence for FI- 
BBM.t Fab-labeled cells were determined by measuring the fluores- 
cence of E-3K  b cells stained  with  F1-BBM.1 Fab that were not 
pulsed with human fl2M. 
FRET.  Cells were prepared for FRET as described above. For 
quenching experiments, cells were labeled with donor FI-5F1-Fab 
and either acceptor TxR-labeled BBM.1-Fab or unlabeled BBM.1- 
Fab. For  sensitized  emission,  cells  were labeled  with  acceptor 
TxR-BBM.1 Fab alone or with acceptor TxR-BBM.1 Fab and donor 
F1-SF1 Fab. For the reciprocal FRET experiments, quenching was 
measured by use of F1-BBM.1 Fab in the presence of either acceptor- 
TxR-5F1 Fab or unlabeled 5F1 Fab. FRET between the fluorescein 
donor and TxR-acceptor Fab fragments was detected by flow cyto- 
metry. Dual laser (488 and 595 nm) excitation was used to deter- 
mine energy transfer efficiency in  labeled  cell populations.  For 
quenching, the fluorophores were excited at 488 nm and fluores- 
cence was detected at 525 nm. For sensitized  emission,  the cells 
were excited  at 488 nm and emission  was  observed  at 630 nm. 
Fluorescence was measured on a logarithmic scale where significant 
changes are represented by relatively small changes in the histo- 
grams. Data were normalized to a linear scale of equivalent soluble 
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coupled beads (Flow Cytometry Standards Corp.).  On the loga- 
rithmic scale of our flow cytometer (Epics 752; Coulter Corp., Hi- 
aleah, FL), a 25-channel shift in fluorescein intensity is equivalent 
to a twofold change in the level of emission. A 32 channel shift 
in TxR intensity is equivalent to a twofold change in the level of 
emission. The standards for maximum donor fluorescence  were cells 
labeled with F1-5F1 Fab and unlabeled BBM.1 Fab. The standards 
for minimum  acceptor fluorescence were cells labeled with TxR- 
BBM.1 Fab. 
Enhancement of 5F1 Fab fragment binding secondary to stabili- 
zation by the anti-32m mAb BBM.1 was determined by analyzing 
F1-5F1 binding, either alone or in the presence of unlabeled BBM.1 
Fab, for empty and peptide-stabilized H-2K  b molecules. 
With use of either F1-5F1 Fab and excess unlabeled BBM.1 Fab 
or F1-BBM.1 Fab and excess unlabeled 5F1 Fab, there was no evi- 
dence of cross-blocking by either  of the Fab fragments. 
Labeling for Flow Microfluorimetry.  Approximately  106  cells 
were incubated for 60 rain at 4~  with 50 ~1 of indicated purified 
mAb diluted to 10/zg/ml final concentration or for the FRET ex- 
periments  with labeled Fab fragments  as described.  Cells were 
washed twice in PBS and incubated for an additional 40 rain at 
4~  in 50 #1 1/40 dilution of fluorescent F(ab')2 goat anti-mouse 
IgG (Cappel Laboratories, Cochranville, PA) when directly con- 
jugated Fabs were not used. 
Results 
E-3K  b cells were established from EE2H3 cells as previously 
described (19) and express empty H-2K  b molecules that are 
temperature sensitive and can be quantitatively loaded with 
H-2Kb-binding peptides (see Materials and Methods). Sero- 
logical  analysis  of  E-3K  b  cells  cultured  overnight  with 
human ~2m showed that human ~2m alone stabilized all the 
conformational epitopes recognized by the anti-H-2Kb-spe  - 
cific mAbs (compare black columns in Fig. 1, A and B). This 
is  similar  to previously reported  effects  of human  3am  in 
stabilizing  H-2D a with  H-2K  b (31).  Analysis  of cells  ex- 
pressing  empty H-2K  b molecules cultured  overnight  with 
human 32m and then loaded with different H-2Kb-binding 
peptides showed that peptides stabilized mouse MHC mole- 
cules containing  human  32m in  serologically discrete con- 
formations (Fig. 1 A). This is similar to our own and others' 
(19, 20) previous findings for peptide-dependent serological 
epitopes  associated with  H-2K  b not  stabilized  by human 
32m. The epitopes recognized by mAb 5F1 and 20.8.4 were 
stabilized by the addition of 32m alone, and only slight in- 
creases in mAb binding were seen with the addition of either 
of the two H-2Kb-binding peptides OVA (257-264) or VSV 
NP (52-59) (Fig. 1 A). The epitope recognized by mAb 28.8.6 
was stabilized by the  addition  of 32m  alone  and by OVA 
(257-264) peptide and ~2m; however, mAb 28.8.6 binding 
was markedly reduced when H-2K  b was stabilized by VSV 
NP (52-59)  peptide and ~2m.  The  epitope recognized by 
34.4.20 was significantly decreased when stabilized by OVA 
(257-264) peptide and 32m, but was not changed by addi- 
tion of the VSV NP (52-59) peptide. Control MHC-binding 
peptides,  which  bind  to  other  MHC  molecules  but  not 
H-2K  b, did not affect any of the mAb reactivity analyzed 
and gave results similar to those obtained when no peptides 
were added  (data not  shown). 
To see if the peptide-stabilized forms of H-2K  b reflect con- 
formational changes in the molecular structure, we analyzed 
cell surface  MHC molecules by FRET measured in a flow 
cytometer (26).  FRET was used to analyze the conforma- 
tional relationship  of two regions in the MHC-32m-pep- 
tide complex, the ol2 region of H-2K  b and/~2m. The donor 
fluorophore,  fluorescein, was conjugated to Fab fragments 
of mAb 5F1 (F1-5F1), which binds to an epitope on the c~2 
region of H-2K  b. This epitope was chosen since it is on the 
c,2 helix, which has been shown to undergo slight peptide- 
dependent conformational changes with peptide binding (15, 
17). Also the 5F1 epitope is stabilized by the addition of both 
peptides used (Fig.  1). The acceptor fluorophore, TxR, was 
conjugated to Fab fragments of BBM.I(TxR-BBM.1), which 
binds human 32m even when associated with mouse MHC 
heavy chain. 
The efficiency of FRET depends on the spectral properties 
of a particular donor/acceptor pair,  their spatial orientation, 
and the inverse sixth power of the distance between the two. 
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Figure  1.  H-2Kb-binding peptides stabilize specific epitopes on cell sur- 
face H-2K  b molecules treated  overnight  with human B2m. E-3K  b cells 
were incubated  overnight  with (A) or without (B) human 32m. Cells 
were then pulsed with either OVA (257-264) (•)  or VSV (52-59)  (Q) 
peptides or without any added peptides and cultured at 37~  (m) or left 
at 22~  (VA) and analyzed by flow cytometry. Cells pulsed with peptides 
were cultured as described. 
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energy transfer Ro is 39A  (Hochman, J.,  and M.  Edidin, 
unpublished data).  Hence, assuming an average  orientation 
of donor and acceptor molecules (K  2 =  2/3), FRET should 
be detectable only when  the two are separated by m80 A 
or less. 
Ifpeptide binding significantly changed the affinity of Fab 
fragments for H-2K  b molecules, then Fab fragments might 
bind  to  H-2K  b  in  slightly  different,  peptide-dependent, 
configurations. Were this the case, FRET measurements could 
simply reflect a difference in the relative orientation  of the 
Fab molecules and not reflect changes in the MHC confor- 
mation. To control for this, we measured the affinity of the 
5F1 and BBM.1 Fab fragments for empty and peptide-loaded 
H-2K  b molecules.  Scatchard analysis  of specific binding  of 
F1-5F1 Fab fragments showed that there were '~45,000 sites 
with an average KA of 8.2  x  10  s (M-1) in cells expressing 
empty H-2K  b molecules  (Fig.  2 A).  As expected,  peptide 
loading increased the number of accessible H-2K  b sites by 
4-10 fold.  However, the  affinity of the  5F1  Fab for OVA 
(257-264)-loaded H-2K  b molecules was not significantly al- 
tered, K^ "~8.0  x  105 (M- 1) (Fig.  2 B). The affinity of 5F1 
for VSV-stabilized H-2K  b molecules consistently showed a 
two- to fourfold increase over its affinity for empty MHC 
molecules,  K^  "~3.1  x  106 (M -1) (data not  shown).  Pep- 
tide loading did not significantly influence either the number 
of sites or the affinity of the anti-~2m BBM.1 Fab fragment 
for 32m  (Fig.  2,  C  and  D).  In  both  empty and  peptide- 
treated cells,  there were ~300,000 sites with an average K^ 
of 2.0-2.4  x  10  s (M-t). Thus, peptide loading did not sig- 
nificantly alter the affinity of the Fab fragments for the MHC 
complex. In our system, differences  in FRET would be ex- 
pected to directly measure changes in the MHC conforma- 
tional  structure rather  than  a change in the orientation  of 
Fab fragments  relative to  the MHC molecule. 
When  FRET was measured,  cells  that  expressed empty 
class  I  MHC  molecules  showed no  quenching  of F1-5F1 
fluorescence in the presence of TxR-BBM.1 (Fig. 3 AI) and 
a low level of apparent  sensitized emission of TxR-BBM.1 
fluorescence (Fig.  3 BI).  In contrast,  when  empty H-2K  b 
was  loaded  with  OVA  (257-264)  peptide,  both  marked 
quenching of donor fluorescence and sensitized emission of 
acceptor fluorescence were observed (Fig.  3, All and BII). 
The histograms are displayed on a logarithmic scale on which 
quenching is seen as a leftward shift of the distribution  of 
F1-5F1 fluorescence (Fig.  3 All) and sensitized emission is 
seen as a rightward shift of the distribution of TxR-BBM.1 
fluorescence without a significant change in the shape of the 
distribution (Fig.  3 BII). Control peptides had no effect on 
energy transfer (data not shown). The magnitude of energy 
transfer was quantitated by use of standardized fluorophore- 
coated beads, by converting mean channel fluorescence to av- 
erage number of fluorophore molecules per cell.  In the ex- 
periment  shown,  the fluorescence signal was quenched by 
an average  of 22%  in OVA-treated cells. 
It is interesting to note that we found that binding of un- 
labeled  anti-32m  Fab  enhanced  binding  of 5F1  to  empty 
H-2K  b (Fig.  3 (21). Detection of the 5F1 epitope was only 
enhanced by BBM.1 when the anti-32m Fab was added be- 
fore or simultaneous with the addition of F1-5F1 (data not 
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Figure  2.  Affinity of 5F1-Fab fragments for 
empty and peptide-loaded H-2K  b. E-3K  b cells 
were incubated overnight with 32m. The next 
morning, the cells were either not treated with 
any additional peptides (A and C) or pulsed 
with the OVA (257-264)  peptide (B and D) 
as described. Cells were then stained with ei- 
ther varying amounts of F1-5F1 Fab fragments 
(A and B) or F1-BBM.1 Fab fragments (C and 
D). Nonspecific binding plus autofluorescence 
of FI-5F1 Fab-stained cells was always <20% 
for  empty  H-2K  b  molecules  and  <5%  for 
peptide-loaded H-2K  b molecules. Nonspecific 
binding  plus  autofluorescence  of F1-BBM.1 
Fab-stained  cells  was  always  <10%.  Mean 
channel fluorescence data were normalized to 
equivalent soluble fluorescein molecules by use 
of standardized fluorophore-coupled beads. By 
use of a linear fit, Scatchard analysis of the 5F1 
binding data  showed that B/F  =  (3.81e +10) 
-  (8.26e*S)*B  [R^2  =  0.87]  for empty H- 
2K  b  molecules  and  B/F  =  (1.16e TM)  - 
(8.00e+S)*B  [R^2  =  0.85]  for  OVA 
(257-264)-loaded H-2K  b molecules. Scatchard 
analysis of the BBM.I binding data showed that 
B/F  =  (6.69e +t0)  -  (2.0e+5)*B  [K^2  = 
0.86] for empty H-2K  b molecules and B/F  = 
(7.18e +1~  -  (2.4e+S)*B  [R^2  =  0.81]  for 
OVA (257-264)-loaded  H-2K  b molecules. 
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tope in peptide-loaded H-2K  ~ molecules (Fig.  3 CII). These 
results imply that Fab binding to/~zm can stabilize  the con- 
formation of a physically distant  part  of the empty MHC 
complex, the or2 domain of the molecule. Thus, compared 
to peptide-loaded H-2K  ~, empty H-2K  ~ molecules appear to 
be extended and flexible. 
To verify that  the effects seen are due to changes in the 
MHC conformation  and not local membrane artifacts,  we 
compared FRET between F1-5F1 Fab and TxK-BBM.1 Fab 
with FRET between F1-BBM.1 Fab and TxR-5F1 Fab. FRET 
was  analyzed  for  both  empty  and  peptide-loaded  H-2K  ~ 
molecules (Fig. 4).  Empty H-2K  ~ molecules did not show 
any significant quenching of either the F1-SF1 signal or the 
F1-BBM.1  signal (Fig.  4, A  and B). When H-2K  ~ was sta- 
bilized with OVA (257-264), quenching of F1-BBM.1 in the 
presence of TxR-5F1 was 24%  (Fig.  4 D),  comparable to 
quenching  seen with use of F1-5F1 and TxR-BBM.1 (Fig. 
4 C). In the experiment shown, fivefold less F1-5F1 Fab was 
used to stain OVA (257-264) peptide-loaded cells (Fig. 4 C) 
than for cells expressing empty H-2K  ~ molecules (Fig. 4 A). 
This was done to show that FRET was seen in the peptide- 
treated cells even at fluorescence levels comparable to the level 
of fluorescence  seen  when  cells  expressing  empty  H-2K  ~ 
molecules were analyzed. As expected, there was no peptide- 
associated increase in the level of expression of BBM.1 epi- 
tope (compare Fig. 4, B and D), as was seen for the expres- 
sion of the 5F1 epitope. 
The magnitude  of FRET depended on the peptide used 
to stabilize  H-2Kh The greatest quenching (22%) and most 
sensitized emission (50%) was observed when H-2K  b was 
stabilized by OVA (257-264) (Fig. 5). When H-2K  ~ was stao 
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Figure  3.  FKET and enhancement  of 
antibody  binding  on  H-2K  b molecules. 
(.4) Quenching of F1-F51 fluorescence by 
TxR-BBM.1  in empty (AI)  and peptide- 
loaded (All) H-2K  b molecules. (B) Sensi- 
tized emission of TxK-BBM.1 fluorescence 
by F1-F51 in empty (BI) and peptide-loaded 
(1311) H-2Kb molecules. (C) Enhancement 
of 5F1 antibody binding to empty (CI) and 
peptide-loaded (CII) H-2Kb molecules sec- 
ondary  to  stabilization  by  the  anti-B2m 
mAb  BBM.1.  Cells  were  prepared  for 
FRET by incubation overnight with human 
32m (5  x  10-7 M  final concentration). 
The next morning, cells were pulsed with 
the OVA (257-264) peptide (All, 1311, and 
CII) or without any added peptides (.41, 
BI, and CI). At the end of the incubation 
periods, cells were harvested and prepared 
for  flow  microfluorimetric  analysis by 
staining  with  various  Fab  fragments  of 
mAbs.  For quenching experiments,  cells 
were labeled with donor F1-5F1 Fab and 
either acceptor  TxK-labeled BBM.1  Fab 
(solid lines) or unlabeled BBM.1 Fab (dashed 
lines). For sensitized emission, cells were la- 
beled  with  acceptor  TxK-BBM.1  alone 
(dashed lines) or acceptor TxK-BBM.1 and 
donor F1-SF1 Fab (solid lines). Fluorescence 
was measured on a logarithmic scale. FRET 
can be deleted as quenching of fluorescence 
of a donor fluorophore,  fluorescein in our 
experiments,  or as enhanced fluorescence 
of an acceptor molecule,  Texas red (TxR, 
sulforhodamine) in our experiments. Donor 
quenching of fluorescein fluorescence de- 
tected at 525 nm is seen as a leftward shift 
to lower channel numbers  in the distribu- 
tion of fluorescence intensities  in the cell 
population.  Fluorescein-sensitized acceptor 
TxK emission, detected at 630 nm, is seen 
as a rightward shift in the intensity  distribution.  Data were normalized  to a linear  scale of equivalent  soluble fluorescein or TxR molecules by use 
of standardized  fluorophore-coupled  beads. A 25-channel  shift in fluorescein intensity is equivalent  to a twofold change  in the level of emission.  A 
32-channel  shift in TxR intensity is equivalent  to a twofold change in the level of emission.  The standards for maximum donor fluorescence were 
cells labeled with FI-SF1 Fab and unlabeled BBM.1 Fab. The standards for minimum acceptor fluorescence were cells labeled with TxR-BBM.1  Fab. 
Enhancement  of 5F1 antibody  binding secondary to stabilization  by the anti-B2M mAb BBM.1 was determined by analyzing  F1-SF1 binding either 
alone (dashed lines) or in the presence of unlabeled  BBM.1  Fab (solid line) for empty (CI) and peptide-stabilized  (CII)  H-2K  b molecules. 
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Figure 4.  Reciprocal FRET. Quenching of fluorescence in empty (.4 
and B) and OVA (257-264) peptide-loaded  H-2K  b molecules (C and D). 
Cells were prepared for FRET as described (see Fig. 3).  For our usual 
quenching experiments, cells were labeled with donor F1-SF1 Fab and ei- 
ther acceptor TxR-labeled  BBM.1 Fab or unlabeled BBM.1 Fab (A and 
C).  For reciprocal FRET, cells were labeled with the donor F1-BBM.1 
and either acceptor TxR-5F1 Fab or unlabeled 5F1-Fab  (B and D). Where 
quenching was seen (C and D), the curve shifted leftward represents the 
quenched signal: F1-5F1 Fab fluorescence in the presence of TxR-BBM.1 
Fab (C) or the F1-BBM.1 Fab fluorescence in the presence of TxR-5F1 
Fab (/9). Quenched signals are marked by an arrowhead. The data presented 
are smoothed  histograms  for channels 0-180.  There was no significant 
fluorescence in channels >180. 
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bilized by VSV (52-59), there was both less quenching (17%) 
and less sensitized  emission  (26%)  (Fig. 5). 
Discussion 
Epitopes  expressed by empty class I MHC molecules may 
be lost  or  enhanced  when  these  molecules  bind peptides 
(19, 20, 22).  We found these same changes in epitopes for 
H-2K  b molecules associated with human/Szm,  rather  than 
with the mixture of murine and bovine/82m  that is usually 
bound to the class I MHC heavy chain  of murine cells in 
culture.  Exchange  of human for endogenous ~2m allowed 
us to probe the conformation of empty and peptide-loaded 
MHC molecules by FRET, by use of pairs of fluorescent donor 
and acceptor Fab. One member of each pair, 5F1, bound to 
the c~2 domain of the class I MHC heavy chain, whereas the 
other,  BBM.1,  bound to the r 
Apparent  FRET may occur because of factors unrelated 
to changes in MHC conformation. However, the results of 
control experiments  rule out important alternative explana- 
tions of our results and show that the changes in FRET be- 
tween labeled Fab are likely to reflect molecular changes in 
the MHC conformation. First, Fab fragments bind to empty 
and peptide-loaded  MHC with about the same affinity, K^ 
r  x  105 (M -1) for 5F1  Fab and  '-2  x  105 (M -1) for 
BBM.1 Fab. From crystallographic  solutions  of the interac- 
tion of Fab molecules with protein ligands (39), it is clear 
that the complex of Fab fragments with ligands involves up- 
wards of 30 amino  acids on the surfaces of the Fab and the 
ligand. The specificity of interaction is believed to result from 
the remarkable  shape complementarity,  which leads to the 
almost total exclusion of water molecules from the interface. 
If peptide loading significantly altered the binding of Fab by 
blocking some critical sites on the MHC molecule, then one 
would expect to see a large change in Fab affinity. The ab- 
sence of such large changes in the affinity of the Fab for peptide- 
loaded MHC molecules strongly suggests that average orien- 
tation of the bound Fab fragments  is the same in all forms 
of class I MHC molecules considered here. Second, the same 
results for donor fluorescence quenching  were seen whether 
the 5F1 Fab or the BBM.1 Fab fragments  were labeled with 
the fluorescent  donor fluorophore,  fluorescein. Hence,  the 
results are not artifacts of the local environments  of donor 
or acceptor  fluorophores. 
The measured FRET is likely to reflect intra- rather than 
intermolecular energy transfer. Intermolecular energy transfer 
might occur under two different conditions: at very high sur- 
face concentrations of class I MHC molecules or when MHC 
molecules are clustered.  The surface concentration  of class 
I MHC molecules is of the order of 103//xm  2. At this con- 
centration,  the average distance between monomeric mole- 
Figure 5.  Decrease  in donor fluorescence (quenching) or increase in 
acceptor fluorescence depends on the peptide added. Percentage changes 
were calculated from the values of equivalent soluble fluorophores stan- 
dardized with fluorescent beads as described in Fig. 2. 
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donor/acceptor fluorophores is <100 ~  Whereas there are 
reports that human class I MHC molecules form clusters (28) 
and that mouse class I MHC molecules may form disulfide- 
linked dimers (40), all of these muhimeric forms appear to 
lack B2m. Indeed, the addition of exogenous B2m abolishes 
clustering or dimer formation. The cells in our experiments 
were incubated overnight  in a saturating  concentration  of 
human B2m, and one of the Fab used to detect FRET binds 
to an epitope on human ~2m. These experimental conditions 
overwhelmingly  favor monomeric  rather  than  multimeric 
MHC complex formation. In addition, we have failed to ob- 
serve any FRET between an c~1 determinant recognized by 
mAb 20.8.4 and the BBM.1 determinant on ~2m (Schneck, 
J.P., unpublished data). If FRET were due to intermolecular 
energy transfer,  one might also expect to see FRET between 
the epitopes recognized by 20.8.4 and BBM.1. Thus, FRET, 
as described here, is intramolecular between labeled Fab bound 
to the same class I MHC molecule and appears to reflect con- 
formational changes in the class I MHC molecule. The mag- 
nitude of FRET,  10-25%,  measured for uniformly loaded 
H-2K  b molecules, is similar to the levels of intramolecular 
FRET between antibodies to B2m and heavy chain class I 
measured for other MHC molecules either in  the absence 
(27) or in  the presence (40a)  of specific  peptides. 
The lack of significant  FRET between Fab bound to empty 
H-2K  b molecules and the clear evidence for FRET in peptide- 
loaded H-2K  b imply that  the empty molecules in solution 
are more extended and open, occupying a larger volume, than 
peptide-loaded  molecules.  This  is  consistent  with  earlier 
findings that empty class I MHC molecules denature at phys- 
iological temperatures unless stabilized by addition of pep- 
tides or mAb to the MHC molecule (8, 10, 11, 31, 41, 42). 
It is also possible that a difference in the location of the ~/2m 
binding  site causes the observed changes in FRET.  In  the 
presence of peptide,  B2m may bind deeper into  the class I 
heavy chain.  Were this the case, then,  minimally,  peptide- 
induced conformational changes would propagate from the 
groove to the B2m binding  site. 
The flexibility of the extended,  open conformation of empty 
H-2K  b  molecules  is  supported  by  our  observation  that 
binding of an anti-B2m Fab increases the binding of the oe2 
MHC domain-reactive  5F1  Fab.  This implies  that  confor- 
mational  changes  in  the  B2m  can propagate  to  the  heavy 
chain.  Our second observation, consistent with the confor- 
mational instability of the empty heavy chains,  is that pep- 
tide loading changes the class I MHC conformation. These 
peptide-induced changes appear to result in a more compact 
conformation than that seen for the empty molecule. When 
analyzed by nondenaturing SDS-PAGE, empty class II MHC 
molecules also have a "floppy" configuration,  which,  with 
the addition  of peptides, becomes more compact (43, 44). 
The biochemical basis for this difference in the class II struc- 
ture is not well understood.  The differences as detected by 
FRET in the class I  structure  may be analogous to differ- 
ences seen in the change from floppy to compact forms of 
class  II MHC molecules. 
Measurements of the thermal stability of empty and peptide- 
loaded class I MHC molecules showed that peptide binding 
confers significant  stability on the class I MHC molecule (45). 
The thermal transition of these molecules was cooperative, 
implying propagation of conformational changes through their 
structure.  Similarly, our results imply that local changes in 
the class I molecule may propagate over the entire molecule. 
Structural  studies  of the  MHC  molecules  H-2K  b and 
HLA-A2 crystallized with different peptides, show small local 
peptide-dependent  differences in  the  conformation  of the 
MHC molecules (15, 17, 25). Our finding that peptide-loaded 
MHC molecules consistently showed differences in amount 
of FRET is consistent with those findings.  Comparison of 
FRET  for peptide-loaded H-2K  b shows higher  FRET  for 
OVA (257-265)-loaded H-2K  b than for VSV (52-59)-loaded 
H-2K  b.  These  differences  could  reflect  greater  structural 
differences between the molecules in solution than are evi- 
dent in crystal structures,  which may have constraints  im- 
posed on them by the crystallization  process. 
In an analysis  of the influence of peptides on serological 
epitopes expressed on MHC molecules, not only exposed pep- 
tide residues but also buried anchor residues but also buried 
anchor residues influenced expression of serological epitopes 
(19, 20, 23). This was seen when the buried anchor tyrosine 
residues at positions 3 and 5 in the VSV (52-59) peptide were 
substituted with alanine,  and also when anchor residues in 
an  H-2Ld-binding  peptide were substituted.  Our  prelimi- 
nary data suggest that these differences can also be detected 
using FRET (Catipovi~, B.,  unpublished data).  This could 
be secondary to a buried amino acid residue in the antigenic 
peptide altering the surface of the MHC molecule and may 
explain why most anti-VSV (52-59)-specific  H-2Kb-restricted 
CTLs do not recognize target cells pulsed with VSV A5 (46). 
Use of FRET to analyze the MHC conformation may pro- 
vide a system to help determine the influence of engagement 
of peptide  anchor  residues on the  MHC conformation. 
The epitope on H-2K  b recognized by mAb 5F1 is exposed 
at the surface of the molecule and available  for contact by 
the TCR.  Since a relatively small part of an antigenic pep- 
tide bound  to  H-2K  b is available  for interaction  with  the 
TCR (15,  25), these changes in the MHC structure could 
significantly contribute to the transmission  of information 
between the peptide-MHC complex and the TCR.  These 
findings  support  the hypothesis that  TCR recognize both 
foreign antigenic peptide bound to an MHC molecule as well 
as a portion  of an "altered"  self-MHC molecule. 
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